Patents Assigned to Oncotherapeutics
  • Patent number: 8877445
    Abstract: The disclosure relates to methods for identifying a tumor as an E2F-responsive gene over-expressing (ERGO) tumor, methods of determining the likelihood that an ERGO tumor patient will survive to a future date, methods of treating an ERGO tumor in a patient, and methods of selecting patients diagnosed as ERGO tumor prostate cancer patients for aggressive clinical treatment. The methods of the disclosure are applicable to ERGO tumors present in different human organs and tissues such as breast, lung, thyroid, ovary, and prostate.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: November 4, 2014
    Assignee: Intelligent Oncotherapeutics, Inc.
    Inventor: Stanley E. Shackney
  • Publication number: 20120028907
    Abstract: The disclosure relates to methods for identifying a tumor as an E2F-responsive gene over-expressing (ERGO) tumor, methods of determining the likelihood that an ERGO tumor patient will survive to a future date, methods of treating an ERGO tumor in a patient, and methods of selecting patients diagnosed as ERGO tumor prostate cancer patients for aggressive clinical treatment. The methods of the disclosure are applicable to ERGO tumors present in different human organs and tissues such as breast, lung, thyroid, ovary, and prostate.
    Type: Application
    Filed: November 13, 2009
    Publication date: February 2, 2012
    Applicant: Intelligent Oncotherapeutics, Inc.
    Inventor: Stanley E. Shackney
  • Patent number: D349773
    Type: Grant
    Filed: July 29, 1992
    Date of Patent: August 16, 1994
    Assignee: Oncotherapeutics
    Inventors: Patricia J. Malin, Oskar W. Huber